2018
DOI: 10.1136/bcr-2018-226839
|View full text |Cite
|
Sign up to set email alerts
|

Diffuse large B cell lymphoma: cutaneous presentation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
3
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 3 publications
0
3
0
Order By: Relevance
“…Secondary cutaneous involvement of DLBCL is not uncommon, and clinical presentations can vary from nodules to infiltrated plaques 4 . Secondary lymphomas are similar to the primary lymphoma from a histological and immunohistochemical perspective; however, the nodular, well‐demarcated infiltrate of densely packed lymphoid cells in the dermis 5 eliminates this as a diagnosis in our case.…”
Section: Discussionmentioning
confidence: 71%
“…Secondary cutaneous involvement of DLBCL is not uncommon, and clinical presentations can vary from nodules to infiltrated plaques 4 . Secondary lymphomas are similar to the primary lymphoma from a histological and immunohistochemical perspective; however, the nodular, well‐demarcated infiltrate of densely packed lymphoid cells in the dermis 5 eliminates this as a diagnosis in our case.…”
Section: Discussionmentioning
confidence: 71%
“…Depending on the site of involvement, there are 2 distinct subsets: primary cutaneous DLBCL which initially presents on the skin and DLBCL accompanied by secondary spread to the skin [6]. e presence of multiple skin lesions and time of evolution at presentation were associated with poorer prognosis in secondary cutaneous DLBCL [7]. In this patient, we assumed that her cutaneous manifestation was initial presentation of disseminated DLBCL.…”
Section: Discussionmentioning
confidence: 86%
“…Primary cutaneous DLBCL on the leg tends to occur in older women 2. Secondary cutaneous involvement in DLBCL may occur with more extensive skin lesions and indicates poorer prognosis compared with primary cutaneous DLBCL 34…”
mentioning
confidence: 99%